Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026)
Alto Neuroscience (ANRO) posted Share-based Compensation of $3.55 million for Q2 2026, up 77.3% from $2.01 million a year earlier and up 25.8% from the prior quarter.
Powered by 
Analysis
Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Alto Neuroscience was $10.51 million, up 39.5% year-over-year; for FY2025, it came in at $8.11 million, up 6.3% from FY2024.
- In prior years, Alto Neuroscience's Share-based Compensation was $7.63 million in FY2024 (+164.0%) and $2.89 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation in data going back to Q1 2023.
- On a year-over-year basis, Share-based Compensation has increased in each of the last five quarters, with growth averaging 72.4% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2024, with growth of 350.2%; the weakest was Q1 2025, with a decline of 9.7%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.82 million (Q1 2026), $1.95 million (Q4 2025) and $2.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Alto Neuroscience | 957.30 Mn | 135.50 Mn | - | 3.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.55 Mn |
| Mar 31, 2026 | 2.82 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 606,000.00 |
| Sep 30, 2023 | 541,000.00 |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 484,000.00 |
API Access
Alto Neuroscience Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();